Text and Data Mining valid from 2019-07-16
Received: 23 January 2019
Accepted: 14 June 2019
First Online: 16 July 2019
Ethics approval and consent to participate
: Duane A. Mitchell holds ownership interest (including patents) in iOncologi, Inc. Duane A. Mitchell has patented immunotherapy-related technology that has been licensed by Annias Immunotherapeutics, Inc., Celldex Therapeutics, Inc., and Immunomic Therapeutics, Inc. The other authors declare no conflicts of interest.